This inventor holds 3 USPTO granted patents. Top assignee: Chiba University. Active years: 2015-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2021
Title: Innovations by Toshihiko Murayama
Introduction
Toshihiko Murayama is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of fibrosis. With a total of 3 patents to his name, Murayama's work is recognized for its potential impact on medical science.
Latest Patents
Murayama's latest patents include a therapeutic agent for fibrosis and an inhibitor of nuclear translocation of phosphorylated Smad. This innovative therapeutic agent is characterized by its active ingredients, which consist of glucosylceramide synthase inhibitors or lactosylceramide synthase inhibitors, or both. These components work together to inhibit the nuclear translocation of phosphorylated Smad, thereby providing a method for treating and preventing fibrosis.
Career Highlights
Toshihiko Murayama is affiliated with Chiba University, where he continues to advance his research and development in the field of therapeutic agents. His work has garnered attention for its scientific rigor and potential applications in medicine.
Collaborations
Murayama collaborates with esteemed colleagues such as Hiroyuki Nakamura and Atsushi Nishida, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Toshihiko Murayama's contributions to the field of therapeutic agents highlight his role as a leading inventor in Japan. His innovative approaches to treating fibrosis demonstrate the importance of research and collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile